Market shape

Where the FDA-cleared listing universe clusters

Buyer coverage and gaps

Submissions with reviewed workflow tags Definition
10
Documented product families Definition
5
Submissions mapped to those families Definition
10
Submissions with reviewed evaluation guides Definition
8
Submissions with scoped metric records Definition
191
Scoped metric records Definition
607
Submissions with some source-backed IT context Definition
1230
Fully versioned published pairing assertions Definition
0

Submission counts use the same 1230 distinct FDA records. Categories overlap. Do not add them together. Family and metric-record counts use different units. Source coverage is not product quality, commercial availability or purchasing readiness.

Of 1230 directory entries, 0 have qualified public US procurement pricing, 0 have public contract terms, and 1230 have some source-backed IT context, not confirmed versioned pairings. 191 entries have published performance metrics (607 metric records in total). Counts use the same entry cohort and definitions as the homepage.

Buyers can use these gaps to shape vendor demos and RFP questions. Vendors can improve their public profile by correcting exact-version data with source-backed documentation.

Open comparison workspace

Recent FDA-cleared listings

Newest decisions in the dataset

FDA-cleared K253969

ADAS 3D

Adas3D Medical S.L.

Authorized purpose: ADAS 3D supports visualization and analysis of MR and CT images of the heart for individual patients with cardiovascular disease, including patients with myocardial scar from ischemic or non-ischemic heart disease. Qualified professionals may use it for cardiac calculation, quantification, visualization, pre-planning, and electrophysiology procedures; produced data support clinical decision-making and must not be used as irrefutable medical advice or for radiotherapy planning, dose calculation, or treatment delivery.

Modality
Radiological images; modality varies or is not specified in FDA list
Anatomy
Heart; myocardial scar and cardiac structures
Decision
2026-06-29
FDA-cleared K260667

Alturion Series Diagnostic Ultrasound System

Philips Ultrasound, LLC

Authorized purpose: Alturion Series diagnostic ultrasound systems acquire and display ultrasound images and fluid-flow information for the labeled fetal, abdominal, cardiac, cephalic, obstetric, musculoskeletal, ophthalmic, urologic, vascular, small-organ, and lung examinations.

Modality
Ultrasound
Anatomy
Fetus; abdomen; pelvis; small organs; head; heart; peripheral vessels; musculoskeletal anatomy; ophthalmic; urologic organs; and lung
Decision
2026-06-29
FDA-cleared K260714

MammoScreen® (5)

Therapixel

Authorized purpose: Flags calcifications, masses, asymmetries and architectural distortions on compatible FFDM or DBT screening examinations; management must not be based solely on MammoScreen output.

Modality
Mammography/DBT
Anatomy
Breast
Decision
2026-06-26
FDA-cleared K253786

syngo.CT Coronary Cockpit

Siemens Medical Solutions USA, Inc.

Authorized purpose: An extension for syngo.via that assists trained physicians with automated and semi-automated analysis, visualization and reporting of cardiac CT angiography volume datasets for coronary-lesion evaluation, documentation, follow-up and treatment planning.

Modality
CT/CTA
Anatomy
Heart/Cardiovascular
Decision
2026-06-25
FDA-cleared K253560

Enhanced Boundary for PCCT

Ge Medical Systems, LLC

Authorized purpose: Enhanced Boundary for PCCT is a deep-learning CT processing function for improved soft-tissue delineation in routine head examinations with or without contrast.

Modality
CT/CTA
Anatomy
Head
Decision
2026-06-24